419 related articles for article (PubMed ID: 1827161)
1. Immunologic effects of plasmapheresis synchronized with pulse cyclophosphamide in systemic lupus erythematosus.
Dau PC; Callahan J; Parker R; Golbus J
J Rheumatol; 1991 Feb; 18(2):270-6. PubMed ID: 1827161
[TBL] [Abstract][Full Text] [Related]
2. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus.
Huang YP; Perrin LH; Miescher PA; Zubler RH
J Immunol; 1988 Aug; 141(3):827-33. PubMed ID: 3135313
[TBL] [Abstract][Full Text] [Related]
3. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
[TBL] [Abstract][Full Text] [Related]
4. Regulation of immune function by calorie restriction and cyclophosphamide treatment in lupus-prone NZB/NZW F1 mice.
Sun D; Krishnan A; Su J; Lawrence R; Zaman K; Fernandes G
Cell Immunol; 2004 Mar; 228(1):54-65. PubMed ID: 15203320
[TBL] [Abstract][Full Text] [Related]
5. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus].
Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
Ter Arkh; 2000; 72(5):44-9. PubMed ID: 11109620
[TBL] [Abstract][Full Text] [Related]
6. Anti-lymphocyte antibodies in systemic lupus erythematosus.
Winfield JB
Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
8. Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. An interim report of the Lupus Plasmapheresis Study Group.
Euler HH; Guillevin L
Ann Med Interne (Paris); 1994; 145(5):296-302. PubMed ID: 7985935
[TBL] [Abstract][Full Text] [Related]
9. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Kammer GM; Birch RE; Polmar SH
J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
[TBL] [Abstract][Full Text] [Related]
10. IgG anti-lymphocyte antibodies in systemic lupus erythematosus react with surface molecules shared by peripheral T cells and a primitive T cell line.
Minota S; Winfield JB
J Immunol; 1987 Mar; 138(6):1750-6. PubMed ID: 3102598
[TBL] [Abstract][Full Text] [Related]
11. T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis.
Shivakumar S; Tsokos GC; Datta SK
J Immunol; 1989 Jul; 143(1):103-12. PubMed ID: 2525144
[TBL] [Abstract][Full Text] [Related]
12. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
13. IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro.
Volk HD; Diamantstein T
Clin Exp Immunol; 1986 Dec; 66(3):525-31. PubMed ID: 2952381
[TBL] [Abstract][Full Text] [Related]
14. Functional properties of CD8 positive lymphocyte subsets in systemic lupus erythematosus.
Horwitz DA; Linker-Israeli M; Gray JD; Lemoine C
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():49-52. PubMed ID: 2956420
[TBL] [Abstract][Full Text] [Related]
15. The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells.
Huang YP; Miescher PA; Zubler RH
J Immunol; 1986 Dec; 137(11):3515-20. PubMed ID: 2946762
[TBL] [Abstract][Full Text] [Related]
16. Immunoregulatory T lymphocytes in man. Soluble antigen-specific suppressor-inducer T lymphocytes are derived from the CD4+CD45R-p80+ subpopulation.
Damle NK; Childs AL; Doyle LV
J Immunol; 1987 Sep; 139(5):1501-8. PubMed ID: 2887618
[TBL] [Abstract][Full Text] [Related]
17. Systemic lupus erythematosus with deficiency of the T4 epitope on T helper/inducer cells.
Stohl W; Crow MK; Kunkel HG
N Engl J Med; 1985 Jun; 312(26):1671-8. PubMed ID: 2582253
[TBL] [Abstract][Full Text] [Related]
18. Effect of plasmapheresis on T anc B lymphocyte functions in patients with systemic lupus erythematosus: a double blind study.
Tsokos GC; Balow JE; Huston DP; Wei N; Decker JL
Clin Exp Immunol; 1982 May; 48(2):449-57. PubMed ID: 6213330
[TBL] [Abstract][Full Text] [Related]
19. [Role of T lymphocytes in systemic lupus erythematosus].
Zubler RH; Miescher PA
Ann Med Interne (Paris); 1990; 141(3):208-12. PubMed ID: 2195945
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
Devi BS; Van Noordin S; Krausz T; Davies KA
J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
